The novel 2016 WHONeisseria gonorrhoeaereference strains for global quality assurance of laboratory investigations: phenotypic, genetic and reference genome characterization
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The novel 2016 WHONeisseria gonorrhoeaereference strains for global quality assurance of laboratory investigations: phenotypic, genetic and reference genome characterization
Authors
Keywords
-
Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 71, Issue 11, Pages 3096-3108
Publisher
Oxford University Press (OUP)
Online
2016-07-19
DOI
10.1093/jac/dkw288
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Minimap and miniasm: fast mapping and de novo assembly for noisy long sequences
- (2016) Heng Li BIOINFORMATICS
- Molecular tests for the detection of antimicrobial resistant Neisseria gonorrhoeae
- (2016) Nicola Low et al. CURRENT OPINION IN INFECTIOUS DISEASES
- A Phylogenetic and Phenotypic Analysis of Salmonella enterica Serovar Weltevreden, an Emerging Agent of Diarrheal Disease in Tropical Regions
- (2016) Carine Makendi et al. PLoS Neglected Tropical Diseases
- Roary: rapid large-scale prokaryote pan genome analysis
- (2015) Andrew J. Page et al. BIOINFORMATICS
- Is the tide turning again for cephalosporin resistance in Neisseria gonorrhoeae in Europe? Results from the 2013 European surveillance
- (2015) Michelle J. Cole et al. BMC INFECTIOUS DISEASES
- Current and future antimicrobial treatment of gonorrhoea – the rapidly evolving Neisseria gonorrhoeae continues to challenge
- (2015) Magnus Unemo BMC INFECTIOUS DISEASES
- Prospects of untreatable gonorrhea and ways forward
- (2015) David M Whiley et al. Future Microbiology
- Trends inNeisseria gonorrhoeaeSusceptibility to Cephalosporins in the United States, 2006-2014
- (2015) Robert D. Kirkcaldy et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting
- (2015) Lori Newman et al. PLoS One
- Prokka: rapid prokaryotic genome annotation
- (2014) T. Seemann BIOINFORMATICS
- InterProScan 5: genome-scale protein function classification
- (2014) P. Jones et al. BIOINFORMATICS
- Characterisation of bla TEM genes and types of β-lactamase plasmids in Neisseria gonorrhoeae – the prevalent and conserved bla TEM-135 has not recently evolved and existed in the Toronto plasmid from the origin
- (2014) Ibrahim Muhammad et al. BMC INFECTIOUS DISEASES
- Antimicrobial Resistance in Neisseria gonorrhoeae in the 21st Century: Past, Evolution, and Future
- (2014) M. Unemo et al. CLINICAL MICROBIOLOGY REVIEWS
- Four treatment failures of pharyngeal gonorrhoea with ceftriaxone (500 mg) or cefotaxime (500 mg), Sweden, 2013 and 2014
- (2014) D Golparian et al. Eurosurveillance
- Antimicrobial resistance, genetic resistance determinants for ceftriaxone and molecular epidemiology of Neisseria gonorrhoeae isolates in Nanjing, China
- (2014) Shao-Chun Chen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Molecular approaches to enhance surveillance of gonococcal antimicrobial resistance
- (2014) Namraj Goire et al. NATURE REVIEWS MICROBIOLOGY
- A New Multidrug-Resistant Strain of Neisseria gonorrhoeae in Australia
- (2014) Monica M. Lahra et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of Amino Acids Conferring High-Level Resistance to Expanded-Spectrum Cephalosporins in thepenAGene from Neisseria gonorrhoeae Strain H041
- (2013) Joshua Tomberg et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- First Three Neisseria gonorrhoeae Isolates with High-Level Resistance to Azithromycin in Sweden: a Threat to Currently Available Dual-Antimicrobial Regimens for Treatment of Gonorrhea?
- (2013) Magnus Unemo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Failure of 500 mg of ceftriaxone to eradicate pharyngeal gonorrhoea, Australia
- (2013) M. Y. Chen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England and Wales, 2007–2011
- (2013) Catherine A Ison et al. LANCET INFECTIOUS DISEASES
- MEGA6: Molecular Evolutionary Genetics Analysis Version 6.0
- (2013) Koichiro Tamura et al. MOLECULAR BIOLOGY AND EVOLUTION
- Nonhybrid, finished microbial genome assemblies from long-read SMRT sequencing data
- (2013) Chen-Shan Chin et al. NATURE METHODS
- One confirmed and one suspected case of pharyngeal gonorrhoea treatment failure following 500mg ceftriaxone in Sydney, Australia
- (2013) Phillip J. Read et al. Sexual Health
- Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea
- (2012) Magnus Unemo et al. Future Microbiology
- Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain
- (2012) J. Camara et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The serious threat of multidrug-resistant and untreatable gonorrhoea: the pressing need for global action to control the spread of antimicrobial resistance, and mitigate the impact on sexual and reproductive health
- (2012) Francis Ndowa et al. SEXUALLY TRANSMITTED INFECTIONS
- Evolution ofNeisseria gonorrhoeaeis a continuing challenge for molecular detection of gonorrhoea: false negative gonococcalporAmutants are spreading internationally
- (2012) Catherine A Ison et al. SEXUALLY TRANSMITTED INFECTIONS
- Is Neisseria gonorrhoeae Initiating a Future Era of Untreatable Gonorrhea?: Detailed Characterization of the First Strain with High-Level Resistance to Ceftriaxone
- (2011) Makoto Ohnishi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- High-Level Cefixime- and Ceftriaxone-Resistant Neisseria gonorrhoeae in France: NovelpenAMosaic Allele in a Successful International Clone Causes Treatment Failure
- (2011) Magnus Unemo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- BLAST Ring Image Generator (BRIG): simple prokaryote genome comparisons
- (2011) Nabil-Fareed Alikhan et al. BMC GENOMICS
- Review and International Recommendation of Methods for Typing Neisseria gonorrhoeae Isolates and Their Implications for Improved Knowledge of Gonococcal Epidemiology, Treatment, and Biology
- (2011) M. Unemo et al. CLINICAL MICROBIOLOGY REVIEWS
- A Novel Mechanism of High-Level, Broad-Spectrum Antibiotic Resistance Caused by a Single Base Pair Change in Neisseria gonorrhoeae
- (2011) E. A. Ohneck et al. mBio
- Molecular and Structural Analysis of Mosaic Variants of Penicillin-Binding Protein 2 Conferring Decreased Susceptibility to Expanded-Spectrum Cephalosporins inNeisseria gonorrhoeae: Role of Epistatic Mutations
- (2010) Joshua Tomberg et al. BIOCHEMISTRY
- Fast and accurate long-read alignment with Burrows–Wheeler transform
- (2010) Heng Li et al. BIOINFORMATICS
- Reduced susceptibility to ceftriaxone in Neisseria gonorrhoeae is associated with mutations G542S, P551S and P551L in the gonococcal penicillin-binding protein 2
- (2010) D. M. Whiley et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Conjugative Plasmids of Neisseria gonorrhoeae
- (2010) Emilia Pachulec et al. PLoS One
- BLAST+: architecture and applications
- (2009) Christiam Camacho et al. BMC BIOINFORMATICS
- Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes
- (2009) M. Unemo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Ceftibuten Resistance and Treatment Failure of Neisseria gonorrhoeae Infection
- (2008) J. Y. C. Lo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- MtrR Modulates rpoH Expression and Levels of Antimicrobial Resistance in Neisseria gonorrhoeae
- (2008) J. P. Folster et al. JOURNAL OF BACTERIOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started